• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Infographics COVID-19 & Viral Hepatitis Care

COVID-19 & Viral Hepatitis Care

November 19, 2020

In collaboration with the National Viral Hepatitis Roundtable (NVHR), the Hepatitis Education Project (HEP), NASTAD, Hep B United, and Hepatitis B Foundation, HepVu deployed a survey to measure the impact of the COVID-19 pandemic on viral hepatitis, and the experiences of clinical providers, community-based organizations, and health departments during COVID-19.

The findings show significant reduction in viral hepatitis testing, vaccination, linkage to care, and outreach across all settings, and offer suggestions on the top resources needed to support these vital viral hepatitis programs.

Most Read

Hepatitis C Treatment Restrictions
Combatting Hepatitis C Among People Who Use Drugs in Appalachia
What’s New in Viral Hepatitis – February
Share Facebook Twitter LinkedIn Email

Keep Reading

February 2, 2023

HepVu Welcomes New HepVu Technical Advisory Group

Read More

February 2, 2023

What's New in Viral Hepatitis - February 2023

Read More

December 14, 2022

2022: A Year in Review

Read More

December 12, 2022

HepVu Adds 2020 County-Level Opioid Maps and Data

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.